← Evidence map

ArticleVaccine: X2019

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.

Thomas P Monath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

61 papers cite itlatest 60 shown

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31384731